Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bailie

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Clinical Pharmacokinetics|June 1, 1990
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysisD Neal, G R Bailie
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Cost/benefit analysis of aminoglycoside use without a kinetic dosing serviceG R Bailie, A Mathews
The Annals of Pharmacotherapy|November 1, 1992
Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversyG R Bailie, G Eisele
Therapeutic Drug Monitoring|January 1, 1988
Quantitative and qualitative assessment of serum concentration monitoring and dosage adjustment of aminoglycosidesG R Bailie, A Mathews
Clinical Nephrology|May 1, 1990
Cyclosporine-associated arthralgiaG R Bailie, G Eisele
Renal Failure|January 1, 1994
Simplified approach to calculation of V, G, and nPCR for monitoring hemodialysis patientsJ Wharton, G R Bailie
Journal of Clinical Pharmacy and Therapeutics|December 1, 1987
Is aminoglycoside-associated nephrotoxicity uncommon in the U.K?G R Bailie, A Mathews
Journal of Clinical Pharmacy and Therapeutics|April 1, 1988
Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysisG R Bailie, S Waldek
The Journal of Antimicrobial Chemotherapy|May 1, 1995
Pharmacokinetic issues in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitisG R Bailie, G Eisele
Archives of Internal Medicine|July 8, 1996
New York State primary care physicians' attitudes to community pharmacists' clinical servicesG R Bailie, B Romeo
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Clinical Pharmacokinetics|June 1, 1990
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysisD Neal, G R Bailie
Drug Intelligence & Clinical Pharmacy|January 1, 1988
Cost/benefit analysis of aminoglycoside use without a kinetic dosing serviceG R Bailie, A Mathews
The Annals of Pharmacotherapy|November 1, 1992
Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversyG R Bailie, G Eisele
Therapeutic Drug Monitoring|January 1, 1988
Quantitative and qualitative assessment of serum concentration monitoring and dosage adjustment of aminoglycosidesG R Bailie, A Mathews
Clinical Nephrology|May 1, 1990
Cyclosporine-associated arthralgiaG R Bailie, G Eisele
Renal Failure|January 1, 1994
Simplified approach to calculation of V, G, and nPCR for monitoring hemodialysis patientsJ Wharton, G R Bailie
Journal of Clinical Pharmacy and Therapeutics|December 1, 1987
Is aminoglycoside-associated nephrotoxicity uncommon in the U.K?G R Bailie, A Mathews
Journal of Clinical Pharmacy and Therapeutics|April 1, 1988
Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysisG R Bailie, S Waldek
The Journal of Antimicrobial Chemotherapy|May 1, 1995
Pharmacokinetic issues in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitisG R Bailie, G Eisele
Archives of Internal Medicine|July 8, 1996
New York State primary care physicians' attitudes to community pharmacists' clinical servicesG R Bailie, B Romeo
Pageof 22